Login

Unaudited Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q3 FY2023
As of Sep 30, 2023
Q4 FY2023
As of Dec 31, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable - trade, net of allowance for credit losses of $4,185 as of September 30, 2024 and $4,282 as of December 31, 2023
Other receivables, net of allowance for credit losses of $877 as of September 30, 2024 and 0 as of December 31, 2023
Inventories
Contract assets
Prepaid expenses and other current assets
Current assets held for sale
Total current assets
Property, plant and equipment, net
Right-of-use assets from operating leases
Goodwill
Intangible assets, net
Long-term restricted cash
Deferred tax assets, net
Other assets
Non-current assets held for sale
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable - trade
Revolving credit facility
Short-term debt – bank, trade facilities and secured borrowings
Current portion of long-term debt
Contract liabilities
Operating lease liabilities
Accrued and other liabilities
Current liabilities held for sale
Total current liabilities
Long-term debt, net of current portion
Long-term debt
Contract liabilities - non-current
Operating lease liabilities - non-current
Pension liabilities
Other long-term liabilities
Non-current liabilities held for sale
Total liabilities
Stockholders’ equity:
Common stock, $0.001 par value, 72,000 shares authorized, 38,741 and 32,122 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.
Preferred Stock, Par or Stated Value Per Share
Preferred stock, $0.001 par value, 25,000 shares authorized and no shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support